MENINGITIS DIAGNOSTIC TESTING MARKET ANALYSIS

Regional Analysis

Meningitis Diagnostic Testing Market- Regional Analysis

However, lack of access to newer diagnostics technology by people in low income countries may restrain growth of the market. Moreover, lack of diagnostic laboratory infrastructure in developing countries is one of the major restraint for the Meningitis Diagnostic Testing Market. Nevertheless, this can be improved by using test that do not require laboratory support including rapid tests for use at the point-of-care.

On the basis of region, the global meningitis diagnostics testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Geographically, North America is expected to hold dominant position in the global meningitis diagnostic testing market over the forecast period, owing to early adoption of diagnostic technologies by the major players. Moreover, major players in the North America meningitis diagnostic testing market are focused on adopting acquisition and collaboration strategies to enhance their market share. This in turn is expected to boost the market growth. For instance, in September 2018, Quest Diagnostics acquired the U.S. laboratory services business of Oxford Immunotec. This acquisition is expected to expand capabilities of Quest Diagnostics in infectious disease diagnostics to accelerate growth of the company by increasing access to diagnostic innovation.

Furthermore, presence of key players in Asia Pacific is expected to increase growth of the meningitis diagnostics testing market in the region. For instance, in May 2017 Seegene Inc., announced that it has entered into a new strategic collaboration agreement with India-based Thermo Fisher Scientific. The collaboration was filed to the U.S Food and Drug Administration (FDA) for clearance of AllplexTM diagnostic assay by Seegene Inc. Thermo Fisher filed for U.S.FDA clearance to run Seegene’s assays on Thermo Fisher’s QuantStudio 5 Real-Time PCR System.

Increasing prevalence of meningitis in Africa is expected to contribute to significant growth of the meningitis diagnostics market in the region. For instance, according to a report by World Health Organization (WHO), February 2018, major epidemics of meningococcal disease have occurred within the African meningitis belt (Lapeysonnie). These epidemics are very disruptive, requiring the establishment of emergency treatment centers to offer proper treatment to the patients in the region.